Floatz logo

ADVICOR COMPONENT NIACIN

Growth Hormone Deficiency

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)Small moleculePhase 1/2Dormant
CCC
48/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Growth Hormone Deficiency cohort.

Asset / SponsorPhaseRating
Genotropin
University of Calgary
Phase 4BBB
Omnitrope
University Hospital, Toulouse
Phase 4BB
Tesamorelin
Columbia University
Phase 4B
Growth Hormone Releasing Hormone 1-44
Massachusetts General Hospital
Phase 2B
Recombinant Gh Saizen
Federico II University
Phase 3NR

Same molecule, other indications

ADVICOR COMPONENT NIACIN is also rated in:

inherited lipid metabolism disorderDormant
BBB
Indicative ·
73 / 100
View asset →
coronary artery disorderDormant
BBB
Indicative ·
73 / 100
View asset →
stroke disorderDormant
BB
Indicative ·
71 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →